DevPro Biopharma is a Clinical Research and Development Accelerator with the mission to design, develop, and deliver molecules into medicines. Our corporate vision is to be a force for continual change in clinical development, focused on bringing medicines to people faster and more efficiently. DevPro Biopharma’s unique capabilities allow the team to span full development programs, with focus on the complete development cycle through global regulatory approvals.
| Website | http://www.devprobiopharma.com |
| Revenue | $15.7 million |
| Employees | 62 (42 on RocketReach) |
| Founded | 2020 |
| Industry | Biotechnology Research |
| Keywords | Biologics, Biopharmaceutical Development, New Drug Applications, Clinical Research, Drug Development, Pharmaceutical Research, Biotechnology, Clinical Trials, Drug Discovery, Medicine Development, Molecular Medicine, Therapeutic Development, Pharmaceutical, Biopharma, Clinical Stage, Accelerator, Research And Development, Life Sciences, Drug Manufacturing, Healthcare |
| Competitors | Roche, GSK, AstraZeneca, Bristol Myers Squibb, Amgen, Regeneron, Gilead Sciences, Moderna Therapeutics, Pfizer, CureVac +42 more (view full list) |
Looking for a particular DevPro Biopharma employee's phone or email?
The DevPro Biopharma annual revenue was $15.7 million in 2026.
Colin Reisner is the CEO and Co-Founder of DevPro Biopharma.
42 people are employed at DevPro Biopharma.